Effectiveness of Malaria Treatments in Pregnant Women in Burkina Faso
Author Information
Author(s): Coulibaly Sheick Oumar, Nezien Désiré, Traoré Salifou, Koné Bibiane, Magnussen Pascal
Primary Institution: Laboratoire National de Santé Publique, Burkina Faso
Hypothesis
What is the efficacy of sulphadoxine-pyrimethamine and chloroquine for treating uncomplicated malaria in pregnant women?
Conclusion
Chloroquine is no longer effective for treating malaria in pregnant women, while sulphadoxine-pyrimethamine remains effective but should be used cautiously to prevent resistance.
Supporting Evidence
- Chloroquine showed a high failure rate of 46.7% in treating malaria.
- Sulphadoxine-pyrimethamine had a failure rate of only 12.9%.
- SP treatment resulted in a significant increase in hemoglobin levels by day 28.
Takeaway
This study looked at how well two malaria medicines work for pregnant women. One medicine doesn't work anymore, but the other still helps, though we need to be careful not to use it too much.
Methodology
The study assessed the clinical efficacy of SP and CQ in pregnant women with uncomplicated malaria using a 28-day follow-up design.
Potential Biases
Potential bias due to low attendance at antenatal care and reliance on self-reported symptoms.
Limitations
The study did not specifically address safety and compliance with treatment regimens.
Participant Demographics
Participants were primarily young women (median age 20) with a majority being primigravidae and living in less developed areas.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website